The Challenge of Managing Atrial Fibrillation During Pregnancy

The incidence of atrial fibrillation (AF) during pregnancy increases with maternal age and with the presence of structural heart disorders. Early diagnosis and prompt therapy can considerably reduce the risk of thromboembolism. The therapeutic approach to AF during pregnancy is particularly challenging, and the maternal and fetal risks associated with the use of antiarrhythmic and anticoagulant drugs must be carefully evaluated. Moreover, the currently used thromboembolic risk scores have yet to be validated for the prediction of stroke during pregnancy. At present, electrical cardioversion is considered to be the safest and most effective strategy in women with hemodynamic instability. Beta-selective blockers are also recommended as the first choice for rate control. Antiarrhythmic drugs such as flecainide, propafenone and sotalol should be considered for rhythm control if atrioventricular nodal-blocking drugs fail. AF catheter ablation is currently not recommended during pregnancy. Overall, the therapeutic strategy for AF in pregnancy must be carefully assessed and should take into consideration the advantages and drawbacks of each aspect. A multidisciplinary approach with a "Pregnancy-Heart Team" appears to improve the management and outcome of these patients. However, further studies are needed to identify the most appropriate therapeutic strategies for AF in pregnancy.

Citing Articles

Multidisciplinary Approach in Atrial Fibrillation: As Good as Gold.

Luca F, Abrignani M, Oliva F, Canale M, Parrini I, Murrone A J Clin Med. 2024; 13(16).

PMID: 39200763 PMC: 11354619. DOI: 10.3390/jcm13164621.

References

Pruyn S, Phelan J, Buchanan G . Long-term propranolol therapy in pregnancy: maternal and fetal outcome. Am J Obstet Gynecol. 1979; 135(4):485-9. DOI: 10.1016/0002-9378(79)90436-8. View

Khairy P, Ouyang D, Fernandes S, Lee-Parritz A, Economy K, Landzberg M . Pregnancy outcomes in women with congenital heart disease. Circulation. 2006; 113(4):517-24. DOI: 10.1161/CIRCULATIONAHA.105.589655. View

Gowda R, Khan I, Mehta N, Vasavada B, Sacchi T . Cardiac arrhythmias in pregnancy: clinical and therapeutic considerations. Int J Cardiol. 2003; 88(2-3):129-33. DOI: 10.1016/s0167-5273(02)00601-0. View

Tita A, Szychowski J, Boggess K, Dugoff L, Sibai B, Lawrence K . Treatment for Mild Chronic Hypertension during Pregnancy. N Engl J Med. 2022; 386(19):1781-1792. PMC: 9575330. DOI: 10.1056/NEJMoa2201295. View

Nakagaki A, Inami T, Minoura T, Baba R, Iwase S, Sato M . Differences in autonomic neural activity during exercise between the second and third trimesters of pregnancy. J Obstet Gynaecol Res. 2016; 42(8):951-9. DOI: 10.1111/jog.12990. View

Alsagaff M, Oktaviono Y, Dharmadjati B, Lefi A, Al-Farabi M, Gandi P . Electrocardiography on admission is associated with poor outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis. J Arrhythm. 2021; 37(4):877-885. PMC: 8339106. DOI: 10.1002/joa3.12573. View

Risius T, Mortensen K, Meinertz T, Willems S . Cluster of multiple atrial tachycardias limited to pregnancy after radiofrequency ablation following senning operation. Int J Cardiol. 2007; 123(3):e48-50. DOI: 10.1016/j.ijcard.2006.11.124. View

Creanga A, Syverson C, Seed K, Callaghan W . Pregnancy-Related Mortality in the United States, 2011-2013. Obstet Gynecol. 2017; 130(2):366-373. PMC: 5744583. DOI: 10.1097/AOG.0000000000002114. View

Nichols K, Henkin S, Creager M . Venous Thromboembolism Associated With Pregnancy: JACC Focus Seminar. J Am Coll Cardiol. 2020; 76(18):2128-2141. DOI: 10.1016/j.jacc.2020.06.090. View

10.

Chapman A, Abraham W, Zamudio S, Coffin C, Merouani A, Young D . Temporal relationships between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 1998; 54(6):2056-63. DOI: 10.1046/j.1523-1755.1998.00217.x. View

11.

Diker E, Aydogdu S, Ozdemir M, Kural T, Polat K, Cehreli S . Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol. 1996; 77(1):96-8. DOI: 10.1016/s0002-9149(97)89145-x. View

12.

Akagi Y, Iketaki A, Nakamura R, Yamamura S, Endo M, Morikawa K . Association between Cerebral Infarction Risk and Medication Adherence in Atrial Fibrillation Patients Taking Direct Oral Anticoagulants. Healthcare (Basel). 2021; 9(10). PMC: 8544438. DOI: 10.3390/healthcare9101313. View

13.

Berruezo A, Diez G, Berne P, Esteban M, Mont L, Brugada J . Low exposure radiation with conventional guided radiofrequency catheter ablation in pregnant women. Pacing Clin Electrophysiol. 2007; 30(10):1299-302. DOI: 10.1111/j.1540-8159.2007.00858.x. View

14.

Anugu V, Nalluri N, Asti D, Gaddam S, Vazzana T, Lafferty J . New-onset lone atrial fibrillation in pregnancy. Ther Adv Cardiovasc Dis. 2016; 10(4):274-6. PMC: 5942632. DOI: 10.1177/1753944716644584. View

15.

CHESLEY L . Plasma and red cell volumes during pregnancy. Am J Obstet Gynecol. 1972; 112(3):440-50. DOI: 10.1016/0002-9378(72)90493-0. View

16.

Ferguson J, Helms A, Mangrum J, DiMarco J . Ablation of incessant left atrial tachycardia without fluoroscopy in a pregnant woman. J Cardiovasc Electrophysiol. 2010; 22(3):346-9. DOI: 10.1111/j.1540-8167.2010.01847.x. View

17.

Lameijer H, Aalberts J, Van Veldhuisen D, Meijer K, Pieper P . Efficacy and safety of direct oral anticoagulants during pregnancy; a systematic literature review. Thromb Res. 2018; 169:123-127. DOI: 10.1016/j.thromres.2018.07.022. View

18.

Cumyn A, Sauve N, Rey E . Atrial fibrillation with a structurally normal heart in pregnancy: An international survey on current practice. Obstet Med. 2017; 10(2):74-78. PMC: 5480646. DOI: 10.1177/1753495X16685684. View

19.

Autore C, Conte M, Piccininno M, Bernabo P, Bonfiglio G, Bruzzi P . Risk associated with pregnancy in hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002; 40(10):1864-9. DOI: 10.1016/s0735-1097(02)02495-6. View

20.

Goland S, Elkayam U . Anticoagulation in pregnancy. Cardiol Clin. 2012; 30(3):395-405. DOI: 10.1016/j.ccl.2012.05.003. View